Protagonist Therapeutics Inc (PTGX)
Cash & Equivalents
$420.08M
Quarterly · Period ending: · USD
PTGX Cash & Equivalents
Latest reported$128.39Mperiod ending
Latest reported$128.39Mperiod ending
PTGX FY Cash & Equivalents ($9.32M → $128.39M)
Annual Cash & Equivalents
High-resolution chart · PNG
PTGX cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 128,390,000 | |
| 97,249,000 | |
| 186,727,000 | |
| 125,744,000 | |
| 123,665,000 | |
| 117,358,000 | |
| 33,006,000 | |
| 82,233,000 | |
| 106,029,000 | |
| 21,084,000 | |
| 4,055,000 | |
| 9,324,000 |